This inventor holds 18 USPTO granted patents and 18 published patent applications and 4 EPO patents, primarily in Chiral Design. Top assignees: Alnylam Pharmaceuticals, Inc., Wave Life Sciences Ltd., Alaylam Pharmacueuticals, Inc.. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
11 out of 466 
6 out of 41 
1 out of 1 
Years Active: 2015-2026
Areas of Expertise:
Title: The Innovative Journey of Ivan Zlatev: A Pioneer in Gene Modulation
Introduction: Ivan Zlatev, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of biotechnology with a total of 17 patents to his name. His work primarily focuses on the modulation of pharmacological activity, advancing the understanding and therapeutic application of gene expression. As a respected figure in his field, Ivan's inventions reflect his commitment to innovation and scientific discovery.
Latest Patents: Ivan's recent patents showcase cutting-edge advancements in gene modulation. His invention of REVERSIR™ compounds relates to agents that modulate the pharmacological activity of conjugated siRNAs, offering new avenues for therapeutic interventions. Additionally, he developed multi-targeted single entity conjugates, which encompass compounds, compositions, and methods effective in modulating gene expression of multiple target nucleic acids through a single chemical entity. These inventions highlight his expertise in exploring complex biological interactions.
Career Highlights: Throughout his career, Ivan has played pivotal roles in prominent biotech companies. Notably, he has worked with Alnylam Pharmaceuticals, Inc., where he contributed to innovative therapies harnessing RNA interference. Furthermore, his tenure at Wave Life Sciences Ltd. allowed him to delve into the development of nucleic acid therapies, positioning him as a leader in the biotechnology landscape.
Collaborations: Collaboration has been a significant aspect of Ivan's career, enabling him to work alongside esteemed colleagues. Noteworthy collaborators include Muthiah Manoharan and Kallanthottathil G Rajeev, both of whom share his vision for advancing biotechnology and transforming medical treatments through innovation.
Conclusion: Ivan Zlatev's journey as an inventor illustrates the profound impact that innovation can have on biotechnology and gene therapy. With an impressive portfolio of patents and a collaborative spirit, he continues to pave the way for future advancements in the field. His work serves as an inspiration for aspiring inventors and researchers aiming to create meaningful solutions for complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile